The weekly litigation news digest is live. Subscribe now

IP Verse

Laboratorios Hipra competitive analysis

Loading summary...

Latest oppositions filed by Laboratorios Hipra

Explore patent oppositions filed by Laboratorios Hipra against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Dec 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2275132
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing ThemBOEHRINGER INGELHEIMMar 4, 2021
EP3320919
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsBOEHRINGER INGELHEIMFeb 24, 2021
EP3127551
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In PigsBOEHRINGER INGELHEIMSep 15, 2020
EP3076996
Vaccine Against Porcine Circo Virus Type 2INTERVETJul 10, 2020
EP2460820
Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsBOEHRINGER INGELHEIMJan 8, 2020
EP2481420
Single Dose Anti-Pcv2 Pig VaccineBOEHRINGER INGELHEIMNov 20, 2019
EP1968630
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsBOEHRINGER INGELHEIMOct 24, 2018

Latest PTAB cases involving Laboratorios Hipra

Discover the latest PTAB cases involving Laboratorios Hipra, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Laboratorios Hipra with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 11, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LABORATORIOS HIPRA7 - - -
BOEHRINGER INGELHEIM49179109
INTERVET113641